- Home
- KNSA vs WSBC Comparison
KNSA vs WSBC Comparison
Compare KNSA & WSBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | KNSA | WSBC |
|---|---|---|
| Founded | 2015 | 1870 |
| Country | United Kingdom | United States |
| Employees | N/A | 2969 |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.5B | 3.5B |
| IPO Year | 2018 | N/A |
Fundamental Metrics
Financial Performance| Metric | KNSA | WSBC |
|---|---|---|
| Price | $46.96 | $36.13 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 4 |
| Target Price | ★ $55.29 | $40.50 |
| AVG Volume (30 Days) | ★ 565.9K | 466.4K |
| Earning Date | 04-28-2026 | 04-21-2026 |
| Dividend Yield | N/A | ★ 4.14% |
| EPS Growth | ★ 225.00 | N/A |
| EPS | ★ 0.75 | N/A |
| Revenue | ★ $677,564,000.00 | N/A |
| Revenue This Year | $38.01 | $11.31 |
| Revenue Next Year | $17.42 | $7.06 |
| P/E Ratio | $63.27 | ★ $16.36 |
| Revenue Growth | ★ 60.09 | N/A |
| 52 Week Low | $19.42 | $26.64 |
| 52 Week High | $50.03 | $38.10 |
Technical Indicators
Market Signals| Indicator | KNSA | WSBC |
|---|---|---|
| Relative Strength Index (RSI) | 51.17 | 63.67 |
| Support Level | $39.96 | $35.85 |
| Resistance Level | $48.14 | $37.03 |
| Average True Range (ATR) | 1.83 | 0.71 |
| MACD | -0.03 | 0.37 |
| Stochastic Oscillator | 45.20 | 78.53 |
Price Performance
Historical ComparisonAbout KNSA Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating cardiovascular diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and Vixarelimab. Geographically, the company earns maximum revenue from United States.
About WSBC WesBanco Inc.
Wesbanco Inc is a bank holding company. Through its subsidiaries, it offers a full range of financial services, including retail banking, corporate banking, personal and corporate trust services, brokerage services, mortgage banking, and insurance. WesBanco operates one commercial bank, WesBanco Bank, which runs scores of branches. The company's reportable segments are Community Banking, which derives key revenue, and Trust and Investment Services. The Community Banking segment offers various banking products and services through various delivery channels, including commercial demand, individual demand, and time deposit accounts; commercial, mortgage, and individual installment loans; and certain non-traditional offerings, such as insurance and securities brokerage services.